NAPWA

New findings from a survey conducted by the National Prescribing Service (NPS) have shed some light on how Australians are using and misusing medicines. read more »

Developing resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. to HIV is by no means a certainty but it is certainly something you want to avoid. Neil McKellar-Stewart explains what it is, how it comes about and what you can do about it. read more »

John Trigg attended the ICAAPInternational Congress on AIDS in Asia and the Pacific. IX Conference as NAPWHA Delegate. Here he reports on his experience of the Conference. read more »

At the turn of the century, combinations of three or more HIV antiviralA medication or substance which is active against one or more virusesA small infective organism which is incapable of reproducing outside a host cell.. May include anti-HIV drugs, but these are more accurately termed antiretroviralsA medication or other substance which is active against retroviruses such as HIV.. drugs were shown to be highly effective in treating HIV disease. At the time it was hoped that after long periods on these drugs it may be possible to ‘eradicate’ HIV from the body. In 2008 it is now known this is not possible with the current treatments. read more »

Adherence (also referred to as compliance) means the extent to which you take the right dose of the drugs at the right time. Taking the right dose at the right time is important. Skipping doses can mean that the drug becomes ineffective against the virusA small infective organism which is incapable of reproducing outside a host cell. and allows resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. to develop, see Resistance. read more »

Doctor Louise Owen answers readers’ questions. This month: preventing resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. and hepatitis vaccinations. read more »

The annual conference of the Australasian Society for HIV Medicine (ASHMAustralasian Society for HIV Medicine. The peak Australasian organisation representing the medical and health sector in HIV/AIDS and related areas. ) was held in Melbourne in November. This article summarises some key developments. read more »

Finding effective treatment options for people who have taken many treatments and have multiple resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. mutations continues to be a significant challenge for HIV clinicians, and their patients. read more »

With the SMART trial making treatment interruptions a much less attractive option for people with HIV, we take a look at one man’s experience of taking a break from treatments. read more »

Thirty-two quick and easy strategies to help you take your medications on time. read more »